Camp4 Therapeutics (CAMP) Earnings Date & Reports

Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CAMP is expected to report earnings to fall 21.87% to -25 cents per share on August 13

Camp4 Therapeutics CAMP Stock Earnings Reports

Q2'26

Est.

$-0.25

Q1'26

Missed

by $0.03

Q4'25

Missed

by $0.59

Q4'23

Missed

by $2.27

Q3'23

Missed

by $0.14

The last earnings report on May 07 showed earnings per share of -31 cents, missing the estimate of -28 cents. With 48.92K shares outstanding, the current market capitalization sits at 218.35M.

View a ticker or compare two or three

Compare

CAMP

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for CAMP